PDCD1 and neoplasm: It has been suggested that this rapid disease progression may be related to PD-1 acting as a tumor suppressor in certain tumor types, further emphasizing the need for clinical studies to focus on biologically distinct subgroups (Wartewig et al., 2017; Ratner et al., 2018).